387 related articles for article (PubMed ID: 24378763)
1. Health characteristics of women beginning postmenopausal hormone therapy: have they changed since the publication of the Women's Health Initiative?
Fournier A; Fritel X; Panjo H; Zins M; Ringa V
Menopause; 2014 Jul; 21(7):687-93. PubMed ID: 24378763
[TBL] [Abstract][Full Text] [Related]
2. Hormone therapy use among postmenopausal French women before the publication of the Women's Health Initiative study: duration of use and factors associated with discontinuation.
Ringa V; Varnoux N; Piault S; Bréart G
Fertil Steril; 2005 Jun; 83(6):1771-9. PubMed ID: 15950650
[TBL] [Abstract][Full Text] [Related]
3. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
[TBL] [Abstract][Full Text] [Related]
4. Persistent hot flushes in older postmenopausal women.
Huang AJ; Grady D; Jacoby VL; Blackwell TL; Bauer DC; Sawaya GF
Arch Intern Med; 2008 Apr; 168(8):840-6. PubMed ID: 18443259
[TBL] [Abstract][Full Text] [Related]
5. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI).
Blümel JE; Chedraui P; Barón G; Benítez Z; Flores D; Espinoza MT; Gomez G; González E; Hernández L; Lima S; Martino M; Montaño A; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Robles C; Saavedra J; Sánchez H; Tserotas K; Vallejo MS; Vallejo C;
Climacteric; 2014 Aug; 17(4):433-41. PubMed ID: 24443950
[TBL] [Abstract][Full Text] [Related]
6. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
[TBL] [Abstract][Full Text] [Related]
7. Hormones down under: hormone therapy use after the Women's Health Initiative.
Travers C; O'Neill SM; Khoo SK; King R
Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):330-5. PubMed ID: 16866795
[TBL] [Abstract][Full Text] [Related]
8. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
Parazzini F;
Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
[TBL] [Abstract][Full Text] [Related]
9. Understanding the impact of the Women's Health Initiative.
Barlow DH
Menopause; 2014 Jul; 21(7):683-4. PubMed ID: 24915507
[No Abstract] [Full Text] [Related]
10. Health-related quality of life in women with or without hot flashes: a randomized placebo-controlled trial with hormone therapy.
Savolainen-Peltonen H; Hautamäki H; Tuomikoski P; Ylikorkala O; Mikkola TS
Menopause; 2014 Jul; 21(7):732-9. PubMed ID: 24219882
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy for the management of menopausal symptoms: pharmacotherapy update.
Woodis CB
J Pharm Pract; 2010 Dec; 23(6):540-7. PubMed ID: 21507860
[TBL] [Abstract][Full Text] [Related]
12. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
13. Shared decision-making on the use of hormone therapy: a nationwide survey in the Republic of Korea.
An AR; Shin DW; Chun SH; Lee HK; Ko YJ; Lee H; Son KY; Choi HC; Cho B; Lee JK; Kim JG
Menopause; 2014 Jul; 21(7):726-31. PubMed ID: 24378764
[TBL] [Abstract][Full Text] [Related]
14. Use and discontinued use of menopausal hormone therapy by healthy women in Norway: the Hordaland Women's Cohort study.
Espen Gjelsvik B; Straand J; Hunskaar S; Dalen I; Rosvold EO
Menopause; 2014 May; 21(5):459-68. PubMed ID: 23982111
[TBL] [Abstract][Full Text] [Related]
15. Discontinuation of hormone therapy in the French GAZEL cohort 1990-2006.
Ringa V; Fritel X; Varnoux N; Zins M; Quelen C; Bouyer J
Fertil Steril; 2010 Sep; 94(4):1387-1391. PubMed ID: 19748086
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for night sweats and hot flushes in midlife: results from a prospective cohort study.
Herber-Gast GC; Mishra GD; van der Schouw YT; Brown WJ; Dobson AJ
Menopause; 2013 Sep; 20(9):953-9. PubMed ID: 23531688
[TBL] [Abstract][Full Text] [Related]
17. Type of menopause, patterns of hormone therapy use, and hot flashes.
Gallicchio L; Whiteman MK; Tomic D; Miller KP; Langenberg P; Flaws JA
Fertil Steril; 2006 May; 85(5):1432-40. PubMed ID: 16566933
[TBL] [Abstract][Full Text] [Related]
18. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
[TBL] [Abstract][Full Text] [Related]
19. Changing use of hormone therapy among minority women since the Women's Health Initiative.
Helenius IM; Korenstein D; Halm EA
Menopause; 2007; 14(2):216-22. PubMed ID: 17179789
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents.
Heinemann K; Rübig A; Strothmann A; Nahum GG; Heinemann LA
J Womens Health (Larchmt); 2008 Sep; 17(7):1151-66. PubMed ID: 18774896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
